Barriers and Facilitators of Adherence in User-Dependent HIV Prevention Trials, a Systematic Review

References (51)

1. 1 Prevention of HIV-1 Infection with Early Antiretroviral Therapy [DOI]
2. 2 Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men [DOI]
3. 3 Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women [DOI]
4. 4 Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women [DOI]
5. 5 Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana [DOI]
6. 6 Preexposure Prophylaxis for HIV Infection among African Women [DOI]
7. 7 Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial [DOI]
8. 8 A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors [DOI]
9. 9 Antiretroviral Therapy Adherence and Viral Suppression in HIV‐Infected Drug Users: Comparison of Self‐Report and Electronic Monitoring [DOI]
10. 10 Expanding access to HIV treatment through community-based organizations : a joint publication of Sidaction, the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO)
11. 11 Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2 [DOI]
12. 12 Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa [DOI]
13. 13 Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial [DOI]
14. 14 Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial [DOI]
15. 15 Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV Transmission [DOI]
16. 16 Efficacy of Nonoxynol 9 Contraceptive Sponge Use in Preventing Heterosexual Acquisition of HIV in Nairobi Prostitutes [DOI]
17. 17 Effect of Herpes Simplex Suppression on Incidence of HIV among Women in Tanzania [DOI]
18. 18 Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial [DOI]
19. 19 PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial [DOI]
20. 20 SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in Nigeria [DOI]
21. 21 Tenofovir Disoproxil Fumarate for Prevention of HIV Infection in Women: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial [DOI]
22. 22 What's Love Got to Do With It? Explaining Adherence to Oral Antiretroviral Pre-Exposure Prophylaxis for HIV-Serodiscordant Couples [DOI]
23. 23 Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women [DOI]
24. 24 The Elusive Gold Standard [DOI]
25. 25 SAVVY® (C31G) Gel for Prevention of HIV infection in Women: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Ghana [DOI]
26. 26 Effectiveness of Cellulose Sulfate Vaginal Gel for the Prevention of HIV Infection: Results of a Phase III Trial in Nigeria [DOI]
27. 27 Adherence Support Approaches in Biomedical HIV Prevention Trials: Experiences, Insights and Future Directions from Four Multisite Prevention Trials [DOI]
28. 28 The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission [DOI]
29. 29 Adherence and its Measurement in Phase 2/3 Microbicide Trials [DOI]
30. 30 Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa [DOI]
31. 31 ‘The study has taught me to be supportive of her’: empowering women and involving men in microbicide research [DOI]
32. 32 Acceptability of PrEP for HIV Prevention Among Women at High Risk for HIV [DOI]
33. 33 Tests of BufferGel for Contraception and Prevention of Sexually Transmitted Diseases in Animal Models [DOI]
34. 34 Covert Use of Topical Microbicides: Implications for Acceptability and Use [DOI]
35. 35 Long‐Term Impact of Acyclovir Suppressive Therapy on Genital and Plasma HIV RNA in Tanzanian Women: A Randomized Controlled Trial [DOI]
36. 36 Preexposure prophylaxis for the prevention of HIV transmission to women [DOI]
37. 37 Clinical and Virologic Efficacy of Herpes Simplex Virus Type 2 Suppression by Acyclovir in a Multicontinent Clinical Trial [DOI]
38. 38 Co-enrollment in multiple HIV prevention trials — Experiences from the CAPRISA 004 Tenofovir gel trial [DOI]
39. 39 Novel strategies implemented to ensure high participant retention rates in a community based HIV prevention effectiveness trial in South Africa and Zimbabwe [DOI]
40. 40 A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe [DOI]
41. 41 Microbicide trials for preventing HIV/AIDS in South Africa: Phase II trial participants' experiences and psychological needs [DOI]
42. 42 Pregnancy and contraceptive use among women participating in an HIV prevention trial in Tanzania [DOI]
43. 43 A qualitative study of participant adherence in a randomized controlled trial of herpes suppressive therapy for HIV prevention in Tanzania [DOI]
44. 44 Role for direct electronic verification of pharmaceutical ingestion in pharmaceutical development [DOI]
45. 45 A Post-Trial Assessment of Factors Influencing Study Drug Adherence in a Randomized Biomedical HIV-1 Prevention Trial [DOI]
46. 46 Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbicide in Harare, Zimbabwe [DOI]
47. 47 Measurement and predictors of adherence in a trial of HSV suppressive therapy in Tanzania [DOI]
48. 48 Oral Adherence Monitoring Using a Breath Test to Supplement Highly Active Antiretroviral Therapy [DOI]
49. 49 Role of HSV-2 Suppressive Therapy for HIV Prevention [DOI]
50. 50 A Novel Breath Test to Directly Measure Use of Vaginal Gel and Condoms [DOI]
51. 51 A Controlled Trial of Nonoxynol 9 Film to Reduce Male-to-Female Transmission of Sexually Transmitted Diseases [DOI]

Cited by 19

Showing 9 of 19 known citations — external sources report more than can currently be individually listed.

Related research

• Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
• Comparative Analysis of Responses to Covid 19 between Europe, Asia, America and Africa- A Literature Review of Four Nations — shares topic coverage
• Molecular Determinants of Artemisinin Resistance in k13 Gene of Plasmodium falciparum — shares topic coverage
• Potential Impact of Climate Change on Termite Distribution in Africa — shares topic coverage
• The Challenges Facing in Commercial Biotechnology: Its Position in Egypt and Some African Countries — shares topic coverage